Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

Background Controlled release and targeted delivery of the drug payload are the two most
fascinating applications of nanoparticle-based systems explored in the recent past. The …

Lung cancer is the leading cause of cancer-related deaths. Traditional chemotherapy
causes serious toxicity due to the wide bodily distribution of these drugs. Curcumin is a …

Polymeric nanoparticles are one of the most studied strategies in modern medicine for drug
encapsulation. The researchers' main interest is a formulation capable of administering the …

Pulmonary administration of biodegradable polymeric formulation is beneficial in the
treatment of various respiratory diseases. For respiratory delivery, the polymer must be non …

The World Health Organization identifies tuberculosis (TB), caused by Mycobacterium
tuberculosis, as a leading infectious killer. Although conventional treatments for TB exist …

Inhaled drug delivery has been an emerging route for the treatment of lung diseases with
clear advantages over oral and intravenous routes. However, the delivery efficacy is affected …

Background Pulmonary route is an attractive target for both systemic and local drug delivery,
with the advantages of a large surface area, rich blood supply, and absence of first-pass …

Most pathogens enter the body through mucosal surfaces. Therefore, vaccination through
the mucosal route can greatly enhance the mucosal immune response. Vaccination via the …

Due to their excellent in vitro activity against multidrug resistant bacteria, antimicrobial
peptides (AMPs) hold promise for treatment of Pseudomonas aeruginosa lung infections in …